By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Phenex Pharmaceuticals AG 

Donnersbergweg 1

Ludwigshafen    D-67059  Germany
Phone: 49-621-671960-0 Fax: 49-621-671960-10



Company News
Phenex Pharmaceuticals AG Announces Milestone Payment From Janssen Biotech (JNJ) For The Entry Of Rorgt Inhibitor Into Phase I 7/10/2017 11:16:53 AM
Creathor Venture Portfolio-Company Phenex Pharmaceuticals AG Receives 100 M USD Milestone Payment From Gilead (GILD) 1/6/2017 9:59:56 AM
Phenex Pharmaceuticals AG Receives $100M Milestone Payment From Gilead (GILD) 1/5/2017 7:23:38 AM
Gilead Sciences, Inc. (GILD) Snaps Up Liver Disease Treatment from Phenex Pharmaceuticals AG in $470 Million Deal 1/6/2015 6:47:08 AM
Phenex Pharmaceuticals AG Signs License Agreement With Janssen Biotech Inc. for Up to $135 Million 12/17/2012 8:11:40 AM
Phenex Pharmaceuticals AG Initiates Phase I First-in-man Study with its Clinical Development Candidate Px-102 9/19/2011 10:22:48 AM
Phenex Pharmaceuticals AG Begins Phase I First-In-Man Study With its Clinical Development Candidate Px-102 9/15/2011 12:53:47 PM
Phenex Pharmaceuticals AG Receives $7.8 Million in Its Series C Financing Round 9/21/2010 6:34:11 AM